Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation


ORAN İ., ÇINAR C., BOZKAYA H., KORKMAZ M.

JOURNAL OF NEUROINTERVENTIONAL SURGERY, cilt.7, ss.357-362, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 7 Konu: 5
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1136/neurintsurg-2013-011023
  • Dergi Adı: JOURNAL OF NEUROINTERVENTIONAL SURGERY
  • Sayfa Sayıları: ss.357-362

Özet

Background and purpose Pretreatment with dual antiaggregant drugs is accepted as a standard step in intracranial stent implantation. The aim of this study was to determine whether tailored antiaggregant medication based on platelet reactivity testing with multiple electrode aggregometry (Multiplate) yields superior outcomes after intracranial flow-diverting stent (FDS) implantation compared with standard clopidogrel treatment.